{
    "code": 0,
    "data": [
        {
            "sym": "POLYMED",
            "disp": "Poly Medicure",
            "bse_code": 531768,
            "isin": "INE205C01021",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Enclosed",
            "news_id": "ffb2601a-c020-4017-93b9-2dd4a4c8c187",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=de985b3e-7982-450c-a31e-b8981be570ce.pdf",
            "news_date": "2026-02-11 15:16:26",
            "seo": "poly-medicure-ltd",
            "ltp": 1387.6,
            "ch": -98.10000000000014,
            "pch": -6.6029481052702526,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 25718,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "POLYMED",
            "disp": "Poly Medicure",
            "bse_code": 531768,
            "isin": "INE205C01021",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of  Investors/ Analysts Call",
            "news_id": "3469a36d-369e-4999-8f29-4925708b9f88",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f2ad0053-342e-4e58-801e-98e32c788266.pdf",
            "news_date": "2026-02-06 19:09:21",
            "seo": "poly-medicure-ltd",
            "ltp": 1387.6,
            "ch": -98.10000000000014,
            "pch": -6.6029481052702526,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 25718,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "POLYMED",
            "disp": "Poly Medicure",
            "bse_code": 531768,
            "isin": "INE205C01021",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "The Company informed the Exchange about the Investors Presentation on Unaudited Financial Results ( Standalone & Consolidated) for the third quarter and nine months ended on 31st Decembere 2025.",
            "news_id": "e911549f-4da0-4e77-94a3-d4a617a994b9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=aaef19c5-4a0c-4fc8-915e-02ab392a3659.pdf",
            "news_date": "2026-02-05 15:34:58",
            "seo": "poly-medicure-ltd",
            "ltp": 1387.6,
            "ch": -98.10000000000014,
            "pch": -6.6029481052702526,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 25718,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "POLYMED",
            "disp": "Poly Medicure",
            "bse_code": 531768,
            "isin": "INE205C01021",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results (Standalone & Consolidated) For The Third Quarter And Nine Months Ended On 31St December 2025.",
            "news_body": "Attached",
            "news_id": "ca63c6fb-055b-4cdd-b760-d6ca68ef07ab",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2b673af4-7e9d-4c1e-bbd8-361b1758baa3.pdf",
            "news_date": "2026-02-05 15:01:00",
            "seo": "poly-medicure-ltd",
            "ltp": 1387.6,
            "ch": -98.10000000000014,
            "pch": -6.6029481052702526,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 25718,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "POLYMED",
            "disp": "Poly Medicure",
            "bse_code": 531768,
            "isin": "INE205C01021",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Earning Call Transcript",
            "news_id": "9a70669c-63b7-4239-a644-63160031215e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d732241a-17d9-413d-b33d-0b82885f04b4.pdf",
            "news_date": "2025-11-14 11:04:12",
            "seo": "poly-medicure-ltd",
            "ltp": 1387.6,
            "ch": -98.10000000000014,
            "pch": -6.6029481052702526,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 25718,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "POLYMED",
            "disp": "Poly Medicure",
            "bse_code": 531768,
            "isin": "INE205C01021",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Analsyt/Investors Meet",
            "news_id": "509c24b3-300b-41f1-a82e-3b5322060628",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3090b290-5fcc-4b06-bd61-4949eea5d0a3.pdf",
            "news_date": "2025-11-10 21:12:28",
            "seo": "poly-medicure-ltd",
            "ltp": 1387.6,
            "ch": -98.10000000000014,
            "pch": -6.6029481052702526,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 25718,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "POLYMED",
            "disp": "Poly Medicure",
            "bse_code": 531768,
            "isin": "INE205C01021",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investors Presentation for the Unaudited Financial Results (Standalone & Consolidated) for the second Quarter ended 30th September 2025.",
            "news_id": "58455d24-2b41-4ec6-ae44-2a3774887d2c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3d324073-0f89-440f-9b06-18ec3a20ceed.pdf",
            "news_date": "2025-11-08 15:47:27",
            "seo": "poly-medicure-ltd",
            "ltp": 1387.6,
            "ch": -98.10000000000014,
            "pch": -6.6029481052702526,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 25718,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "POLYMED",
            "disp": "Poly Medicure",
            "bse_code": 531768,
            "isin": "INE205C01021",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Declaration Of Unaudited Financial Results For The Second Quarter And Half Year Ended For 30Th September 2025.",
            "news_body": "Unaudited Financial Results",
            "news_id": "f2be69b9-fc10-4cce-810a-76b8823080e3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=71e2be97-fcd7-4aa5-92b3-e7fe5402507c.pdf",
            "news_date": "2025-11-08 15:33:20",
            "seo": "poly-medicure-ltd",
            "ltp": 1387.6,
            "ch": -98.10000000000014,
            "pch": -6.6029481052702526,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 25718,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "POLYMED",
            "disp": "Poly Medicure",
            "bse_code": 531768,
            "isin": "INE205C01021",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of the Analyst/Investor Conference call held on today i.e. 25th September 2025 at 16:00 pm india time.",
            "news_id": "6b1e50a0-7a78-4703-8230-35438526e251",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=10b8500e-c0c7-4d30-914c-b99138f9e274.pdf",
            "news_date": "2025-09-25 18:10:00",
            "seo": "poly-medicure-ltd",
            "ltp": 1387.6,
            "ch": -98.10000000000014,
            "pch": -6.6029481052702526,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 25718,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "POLYMED",
            "disp": "Poly Medicure",
            "bse_code": 531768,
            "isin": "INE205C01021",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Revised Investors Presentation",
            "news_id": "53b9bc39-9243-4c4f-9f0d-27b3fddc1504",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9b04bb12-3eba-4efb-a8f1-8641ca78a36c.pdf",
            "news_date": "2025-09-25 12:25:17",
            "seo": "poly-medicure-ltd",
            "ltp": 1387.6,
            "ch": -98.10000000000014,
            "pch": -6.6029481052702526,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 25718,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "POLYMED",
            "disp": "Poly Medicure",
            "bse_code": 531768,
            "isin": "INE205C01021",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investors Presentation on Acquisition of \"Citieffee Group\"",
            "news_id": "ebfa213a-5b35-4471-8c88-6fd6cb9b8296",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9a078da1-18a5-4d79-ba36-db8f919904c2.pdf",
            "news_date": "2025-09-24 14:45:13",
            "seo": "poly-medicure-ltd",
            "ltp": 1387.6,
            "ch": -98.10000000000014,
            "pch": -6.6029481052702526,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 25718,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "POLYMED",
            "disp": "Poly Medicure",
            "bse_code": 531768,
            "isin": "INE205C01021",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Investor/Analyst Call",
            "news_id": "c3c772ac-183b-4ecb-b717-d4420a6a893e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=49d19e08-3ba1-4d2d-96a3-bfa679cb3f79.pdf",
            "news_date": "2025-09-04 21:45:18",
            "seo": "poly-medicure-ltd",
            "ltp": 1387.6,
            "ch": -98.10000000000014,
            "pch": -6.6029481052702526,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 25718,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "POLYMED",
            "disp": "Poly Medicure",
            "bse_code": 531768,
            "isin": "INE205C01021",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "The Company ahs informed about the Investors presentation on Acquisition of PendraCare Group.",
            "news_id": "bf32c228-cfa2-45fa-93fb-56abb7c96767",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7e5a38b2-9453-4c50-9603-f4965c52ed39.pdf",
            "news_date": "2025-09-03 18:21:16",
            "seo": "poly-medicure-ltd",
            "ltp": 1387.6,
            "ch": -98.10000000000014,
            "pch": -6.6029481052702526,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 25718,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "POLYMED",
            "disp": "Poly Medicure",
            "bse_code": 531768,
            "isin": "INE205C01021",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Analyst/Investor Call transcript",
            "news_id": "9c905aaf-c5d8-4d03-ac53-c2d6583d5a6f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9cb43412-cd15-4b50-b5d6-9594c63349d9.pdf",
            "news_date": "2025-08-14 17:53:57",
            "seo": "poly-medicure-ltd",
            "ltp": 1387.6,
            "ch": -98.10000000000014,
            "pch": -6.6029481052702526,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 25718,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "POLYMED",
            "disp": "Poly Medicure",
            "bse_code": 531768,
            "isin": "INE205C01021",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Outcome of Analyst/Investor Meet  Call- Audio Recording",
            "news_id": "9ce64c2f-e6da-4b2f-800f-084312e5c00c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f563b1e4-67ae-417c-bec2-36a742fb4e43.pdf",
            "news_date": "2025-08-08 18:15:26",
            "seo": "poly-medicure-ltd",
            "ltp": 1387.6,
            "ch": -98.10000000000014,
            "pch": -6.6029481052702526,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 25718,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "POLYMED",
            "disp": "Poly Medicure",
            "bse_code": 531768,
            "isin": "INE205C01021",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investors Presentation for the Financial Results quarter ended 30th June 2025",
            "news_id": "8c7d7501-51ea-417f-8db9-807457ec50ba",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ae6ba797-6b97-44f1-96d9-972e10546943.pdf",
            "news_date": "2025-08-08 15:09:04",
            "seo": "poly-medicure-ltd",
            "ltp": 1387.6,
            "ch": -98.10000000000014,
            "pch": -6.6029481052702526,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 25718,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "POLYMED",
            "disp": "Poly Medicure",
            "bse_code": 531768,
            "isin": "INE205C01021",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Standalone & Consolidated Financial Results For The Quarter Ended 30Th June 2025 Declared As Outcome Of The Board Meeting Held On Today I.E. 08Th August 2025",
            "news_body": "Unaudited Standalone and Consolidated Financial Results for the quarter ended 30th June 2025.",
            "news_id": "b34e74ba-3c5d-461a-961c-e7ae8123d07e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=31c24140-efd4-48e9-8cb0-975d233dfbc6.pdf",
            "news_date": "2025-08-08 14:43:09",
            "seo": "poly-medicure-ltd",
            "ltp": 1387.6,
            "ch": -98.10000000000014,
            "pch": -6.6029481052702526,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 25718,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "POLYMED",
            "disp": "Poly Medicure",
            "bse_code": 531768,
            "isin": "INE205C01021",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of the Earnings call conducted on May 7th 2025",
            "news_id": "e721d882-3de7-42cc-b120-3f2e8b9d5f26",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e05528f4-536e-4cda-adec-707eae1fba60.pdf",
            "news_date": "2025-05-13 17:31:40",
            "seo": "poly-medicure-ltd",
            "ltp": 1387.6,
            "ch": -98.10000000000014,
            "pch": -6.6029481052702526,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 25718,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "POLYMED",
            "disp": "Poly Medicure",
            "bse_code": 531768,
            "isin": "INE205C01021",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Dear Sir/Madam \r\nPursuant to the provisions of Regulation 30 and 46(2) (oa) of the securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations 2015 as amended the audio recording of the Earnings Conference Call held on Wednesday May 07 2025 at 05:00 P.M. Indian time on the Audited Standalone and Consolidated financial results of the Company for the quarter and year ended on March 31 2025.\r\n",
            "news_id": "778fe228-cb72-4c0f-9567-b4ed657e5f79",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bc5db497-10c3-49b9-a330-3d002f002987.pdf",
            "news_date": "2025-05-07 18:42:02",
            "seo": "poly-medicure-ltd",
            "ltp": 1387.6,
            "ch": -98.10000000000014,
            "pch": -6.6029481052702526,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 25718,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "POLYMED",
            "disp": "Poly Medicure",
            "bse_code": 531768,
            "isin": "INE205C01021",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor presentation",
            "news_id": "0f489736-e7f2-49ac-9c55-7a731fb23f9c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=adf2ac6b-b9a6-490d-b18b-31c022632f47.pdf",
            "news_date": "2025-05-06 23:06:01",
            "seo": "poly-medicure-ltd",
            "ltp": 1387.6,
            "ch": -98.10000000000014,
            "pch": -6.6029481052702526,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 25718,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "POLYMED",
            "disp": "Poly Medicure",
            "bse_code": 531768,
            "isin": "INE205C01021",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Standalone & Consolidated Financial Results For The Quarter And Year Ended 31.03.2025",
            "news_body": "Audited Standalone & Consolidated Financial Results for the 31.03.2025",
            "news_id": "50520282-fe60-4295-b3ec-d0d23a484a27",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bbfefef6-1a54-4fa8-a854-38ac3005b388.pdf",
            "news_date": "2025-05-06 22:28:23",
            "seo": "poly-medicure-ltd",
            "ltp": 1387.6,
            "ch": -98.10000000000014,
            "pch": -6.6029481052702526,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 25718,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "POLYMED",
            "disp": "Poly Medicure",
            "bse_code": 531768,
            "isin": "INE205C01021",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Attached",
            "news_id": "947ae3de-0a62-4649-ac2c-f024b3dda7c1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3e1b327a-169a-429c-ada8-3f0d2cf341ba.pdf",
            "news_date": "2025-02-10 14:13:43",
            "seo": "poly-medicure-ltd",
            "ltp": 1387.6,
            "ch": -98.10000000000014,
            "pch": -6.6029481052702526,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 25718,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "POLYMED",
            "disp": "Poly Medicure",
            "bse_code": 531768,
            "isin": "INE205C01021",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "The Company has informed the Exchange about the Investors presentation",
            "news_id": "271d5a1b-b4b2-45a7-84e5-299210ca1444",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fb515904-e559-4896-8c3f-0074163d2803.pdf",
            "news_date": "2025-02-03 14:58:29",
            "seo": "poly-medicure-ltd",
            "ltp": 1387.6,
            "ch": -98.10000000000014,
            "pch": -6.6029481052702526,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 25718,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "POLYMED",
            "disp": "Poly Medicure",
            "bse_code": 531768,
            "isin": "INE205C01021",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results (Standalone & Consolidated) For The  Third Quarter And Nine Months Ended On 31St December 2024",
            "news_body": "The Company has informed about the Unaudited Financial Results ( Standalone & Consolidated ) for the Third quarter and nine months ended  on 31st December 2024",
            "news_id": "f83e20b0-bf74-42e5-9ef8-0afbb3573424",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8121f3e4-6ed0-494c-9018-a1a983a752c3.pdf",
            "news_date": "2025-02-03 14:30:22",
            "seo": "poly-medicure-ltd",
            "ltp": 1387.6,
            "ch": -98.10000000000014,
            "pch": -6.6029481052702526,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 25718,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "POLYMED",
            "disp": "Poly Medicure",
            "bse_code": 531768,
            "isin": "INE205C01021",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "The Company has informed the exchange about the Earning call transcript",
            "news_id": "6ec81e5f-f23a-44d8-b38c-7c773cf90ab4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=505281ea-c025-4d53-8bf7-bd0ee743bb44.pdf",
            "news_date": "2024-11-06 15:32:47",
            "seo": "poly-medicure-ltd",
            "ltp": 1387.6,
            "ch": -98.10000000000014,
            "pch": -6.6029481052702526,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 25718,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "POLYMED",
            "disp": "Poly Medicure",
            "bse_code": 531768,
            "isin": "INE205C01021",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Dear Sir/Madam, Pursuant to the provisions of Regulation 30 and 46(2) (oa) of the securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015, as amended, the audio recording of the Earnings Conference Call held on Tuesday, October 29th, 2024, on the Unaudited Standalone and Consolidated financial results of the Company for the quarter and half year ended on September 30, 2024, is available on the Company's website at https://www.polymedicure.com/wp-content/uploads/2024/10/ICI3420241029156069.mp3",
            "news_id": "dccd0784-b056-4164-bfb9-2aac6dc40452",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9a1c4376-41b9-46dc-957a-6cef1e2e7c48.pdf",
            "news_date": "2024-10-29 17:53:10",
            "seo": "poly-medicure-ltd",
            "ltp": 1387.6,
            "ch": -98.10000000000014,
            "pch": -6.6029481052702526,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 25718,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "POLYMED",
            "disp": "Poly Medicure",
            "bse_code": 531768,
            "isin": "INE205C01021",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter And Half Year Ended On 30Th September, 2024.",
            "news_body": "The Company has informed the Exchange about the Financial Results for the quarter and half year ended on 30th September, 2024 along with limited review report.",
            "news_id": "bf1975da-b25d-421c-aefa-73dde7ed0258",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=62a207d5-1af9-4b4f-84ed-e320fb735878.pdf",
            "news_date": "2024-10-28 14:17:47",
            "seo": "poly-medicure-ltd",
            "ltp": 1387.6,
            "ch": -98.10000000000014,
            "pch": -6.6029481052702526,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 25718,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "POLYMED",
            "disp": "Poly Medicure",
            "bse_code": 531768,
            "isin": "INE205C01021",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Pursuant to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) FRegulations, 2015, we hereby submit Transcript of the investor Meet/Call held on 24th July, 2024, on the Unaudited Financial Results of the Company for the quarter ended 30th June, 224, on Statdalone and Consolidated basis, which were considered and approved by the Board of Directors of the Company, at its meeting held on 22nd July, 2024.",
            "news_id": "5d551b08-2291-4973-becc-04785f328198",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=84d2d3bd-440f-4a26-adb9-7aca9f931642.pdf",
            "news_date": "2024-07-31 12:58:38",
            "seo": "poly-medicure-ltd",
            "ltp": 1387.6,
            "ch": -98.10000000000014,
            "pch": -6.6029481052702526,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 25718,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "POLYMED",
            "disp": "Poly Medicure",
            "bse_code": 531768,
            "isin": "INE205C01021",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Pursuant to the provisions of Regulation 30 and 46(2) (oa) of the securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015, as amended, the audio recording of the Earnings Conference Call held on Wednesday, July 24th, 2024, on the Unaudited Standalone and Consolidated financial results of the Company for the quarter ended on June 30, 2024, is available on the Company's website at https://www.polymedicure.com/wp-content/uploads/2024/07/ICI3420240724154379.mp3",
            "news_id": "fbd1068a-3203-4253-894c-26abb3740bfd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9bd94e8e-1aa0-4912-b9ad-4ccbfd4f0038.pdf",
            "news_date": "2024-07-24 20:15:46",
            "seo": "poly-medicure-ltd",
            "ltp": 1387.6,
            "ch": -98.10000000000014,
            "pch": -6.6029481052702526,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 25718,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "POLYMED",
            "disp": "Poly Medicure",
            "bse_code": 531768,
            "isin": "INE205C01021",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pursuant to Regulation 30, Regulation 51 and other applicable provisions of SEBI(Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the investor''s presentation with respect to Un-audited Financial Results for the first quarter ended on June 30, 2024.",
            "news_id": "6212e79f-5d1d-4662-ade9-9da998bc5c16",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7ccc47c8-aaa5-4dd1-bceb-03b8d8ee3412.pdf",
            "news_date": "2024-07-24 13:04:35",
            "seo": "poly-medicure-ltd",
            "ltp": 1387.6,
            "ch": -98.10000000000014,
            "pch": -6.6029481052702526,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 25718,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "POLYMED",
            "disp": "Poly Medicure",
            "bse_code": 531768,
            "isin": "INE205C01021",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results (Standalone & Consolidated) For The Quarter Ended 30Th June, 2024 In Compliance Of Regulation 30 And 33 Of SEBI (LODR) Regulations, 2015",
            "news_body": "Unaudited Financial Results ( Standalone & Consolidated) for the quarter ended on 30th June, 2024 in compliance of Regulation 30 and 33 of SEBI (LODR) Regulations, 2015",
            "news_id": "8c9641c1-1978-4ca1-a929-3916efb9b672",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4885d662-9c20-4089-9d68-6724a7ba3be1.pdf",
            "news_date": "2024-07-22 13:19:08",
            "seo": "poly-medicure-ltd",
            "ltp": 1387.6,
            "ch": -98.10000000000014,
            "pch": -6.6029481052702526,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 25718,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "POLYMED",
            "disp": "Poly Medicure",
            "bse_code": 531768,
            "isin": "INE205C01021",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "pursuant to Regulation 30(6) of SEBI(LODR) Regulations, 2015, we hereby submit transcript of the investor Meet/Call held on 20th May, 2024, on the Audited Financial Results of the Company for the quarter and year ended on 31st March , 2024, on standalone and consolidated basis, which were considered and approved by the Board of Directors of the Company, at its meeting held on 17th May, 2024.",
            "news_id": "37ae9f05-09a4-4d82-a1b4-e20224262667",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c563081a-3d38-480a-8c5c-6568e767dafc.pdf",
            "news_date": "2024-05-24 15:35:53",
            "seo": "poly-medicure-ltd",
            "ltp": 1387.6,
            "ch": -98.10000000000014,
            "pch": -6.6029481052702526,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 25718,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "POLYMED",
            "disp": "Poly Medicure",
            "bse_code": 531768,
            "isin": "INE205C01021",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Dear Sir/Madam, Pursuant to the provisions of Regulation 30 and 46(2) (oa) of the securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015, as amended, the audio recording of the Earnings Conference Call held on Monday, May 20, 2024, on the Unaudited Standalone and Consolidated financial results of the Company for the quarter ended  March 31, 2024 , is available on the Company's website athttps://www.polymedicure.com/wp-content/uploads/2024/05/ICI3420240520153154.mp3",
            "news_id": "d6df2857-bd3c-41f8-bd55-b0240937348c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c2a3f117-eeda-40e5-ad3c-f0ada772598e.pdf",
            "news_date": "2024-05-21 09:19:53",
            "seo": "poly-medicure-ltd",
            "ltp": 1387.6,
            "ch": -98.10000000000014,
            "pch": -6.6029481052702526,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 25718,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "POLYMED",
            "disp": "Poly Medicure",
            "bse_code": 531768,
            "isin": "INE205C01021",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Dear Sir,Pursuant to Regulation 30, Regulation 51 and other applicable provisions of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the Investor''s Presentation with respect to Audited Financial Results for Quarter and Financial Year ended on March, 2024.The same is also available on the website of the Company i.e. www.polymedicure.com",
            "news_id": "a99dc369-390f-4a66-96ce-d6ff0a2c99a7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d682b4f1-097d-4063-a9b4-9acb52ea6dff.pdf",
            "news_date": "2024-05-17 19:38:10",
            "seo": "poly-medicure-ltd",
            "ltp": 1387.6,
            "ch": -98.10000000000014,
            "pch": -6.6029481052702526,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 25718,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "POLYMED",
            "disp": "Poly Medicure",
            "bse_code": 531768,
            "isin": "INE205C01021",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results (Consolidate & Standalone) For The Fourth Quarter And Financial Year Ended On 31St March 2024 Approved At Board Meeting Held Today I.E. 17Th May, 2024.",
            "news_body": "Pursuant to Regulatiom 30 and 33 of SEBI(LODR) Regulations, 2015, we are pleased to inform the stock exchange that the board of directors of at their meeting held today i.e. 17th May, 2024, at Crowne plaza today, plot No. 1, community centre, okhla -I, New Delhi 110020, approved the Audited Financial Results (Consolidated & Standalone) for the fourth quarter and financial year ended on 31st March, 2024.",
            "news_id": "abebe0d4-d569-4cff-815a-d6051844f28b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d5a7f898-61f6-4151-af44-cdf2ec8b69b3.pdf",
            "news_date": "2024-05-17 14:08:22",
            "seo": "poly-medicure-ltd",
            "ltp": 1387.6,
            "ch": -98.10000000000014,
            "pch": -6.6029481052702526,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 25718,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "POLYMED",
            "disp": "Poly Medicure",
            "bse_code": 531768,
            "isin": "INE205C01021",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Pursuant to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are hereby submit Transcript of the Investor Meet/Call held on 02nd February, 2024 at 04:00 P.M(IST) on the Unaudited Financial Results of the Company for the quarter ended 31st December, 2023 on Standalone and Consolidated basis, which were considered and approved by the Board of Directors of the Company, at its meeting held on 31st January, 2024.",
            "news_id": "ae3fabb8-2781-433a-8a73-9615a465e4b4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7558e17b-2866-44f4-8b06-f2632b5e0b1d.pdf",
            "news_date": "2024-02-09 18:03:33",
            "seo": "poly-medicure-ltd",
            "ltp": 1387.6,
            "ch": -98.10000000000014,
            "pch": -6.6029481052702526,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 25718,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "POLYMED",
            "disp": "Poly Medicure",
            "bse_code": 531768,
            "isin": "INE205C01021",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Dear Sir/Madam, Pursuant to the provisions of Regulation 30 and 46(2)(oa) of the securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015, as amended, the audio recording of the Earnings Conference Call held on Friday, February 02, 2024, on the Unaudited Standalone and Consolidated financial results of the Company for the quarter ended December 31, 2023 , is available on the Company's website athttps://www.polymedicure.com/wp-content/uploads/2024/02/ICI3420240202151273.mp3",
            "news_id": "6c180a95-0b89-4ce5-ac43-1aff333179ea",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=37aab509-b292-471f-b339-8029f96ef5ae.pdf",
            "news_date": "2024-02-03 15:49:22",
            "seo": "poly-medicure-ltd",
            "ltp": 1387.6,
            "ch": -98.10000000000014,
            "pch": -6.6029481052702526,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 25718,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "POLYMED",
            "disp": "Poly Medicure",
            "bse_code": 531768,
            "isin": "INE205C01021",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Quarterly Statndalone & Consolidated Financial Results In Compliance Of Regulation 30 And 33 Of SEBI (LODR) Regulations, 2015 <BR>",
            "news_body": "Quarterly Standalone and Consolidated Financial Results for the quarter ended 31st December, 2023.",
            "news_id": "8f1f5cff-a14f-4be2-a83d-f0af84dd8c0a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6645206e-cb19-4fa8-aff5-509a82efd9df.pdf",
            "news_date": "2024-01-31 11:59:09",
            "seo": "poly-medicure-ltd",
            "ltp": 1387.6,
            "ch": -98.10000000000014,
            "pch": -6.6029481052702526,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 25718,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "POLYMED",
            "disp": "Poly Medicure",
            "bse_code": 531768,
            "isin": "INE205C01021",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting Of The Company Held Today I.E. 31St January, 2024",
            "news_body": "Pursuant to Regulation 30 and 33 of SEBI (LODR) Regulations, 2015, We are pleased to inform the Stock Exchange that the Board of Directors at their meeting held today i.e. 31st January, 2024, at registered office at 232-B, 3rd floor, Okhla industrial estate, PHASE-III, New Delhi -110020, approved the following businesses:<BR> a. On recommendation of Nomination Remuneration Committee approve the reappointment of Shri Dhruv Baid as Senior Manager, International Business Development for Five years with effect from 1st April 2024.<BR> b. Nomination & Remuneration Committee, has allotted 26,375 shares having face value of Rs 5/- each to its eligible employees of the Company who has exercise the option Under its Employee Stock Option Scheme, 2020.<BR> c. Unaudited Financial Results (Consolidate & Standalone) for the Third quarter and Nine months ended on 31st December 2023.<BR> d. Adoption of New set of  Article of Association of the Company. <BR> <BR> e. Any Other Item.<BR>",
            "news_id": "5305a63f-9f0a-4222-b97f-d2101882a7c6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7cbbec75-8d0c-4812-9eb2-99567756a986.pdf",
            "news_date": "2024-01-31 11:51:45",
            "seo": "poly-medicure-ltd",
            "ltp": 1387.6,
            "ch": -98.10000000000014,
            "pch": -6.6029481052702526,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 25718,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "POLYMED",
            "disp": "Poly Medicure",
            "bse_code": 531768,
            "isin": "INE205C01021",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Pursuant to Regulation 30(6) of SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015, we hereby submit transcript of the Investot Meet/Call held on 6th November, 2023, on the Unaudited Financial Results of the Company for the quarter and half year ended on 30th September, 2023, on standalone and consolidated basis, which were considered and approved by the Board of Directors of the Company, at its meeting held on 4th November, 2023.",
            "news_id": "3f4a7727-14a8-4ece-b956-f60f5d2e80ea",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=365d4d3f-24f5-41cb-9f34-cffd63004700.pdf",
            "news_date": "2023-11-10 14:10:01",
            "seo": "poly-medicure-ltd",
            "ltp": 1387.6,
            "ch": -98.10000000000014,
            "pch": -6.6029481052702526,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 25718,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "POLYMED",
            "disp": "Poly Medicure",
            "bse_code": 531768,
            "isin": "INE205C01021",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Dear Sir/Madam, Pursuant to the provisions of Regulation 30 and 46(2)(oa) of the securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015, as amended, the audio recording of the Earnings Conference Call held on Monday, November 06, 2023, on the Unaudited Standalone and Consolidated financial results of the Company for the quarter ended September 30, 2023.",
            "news_id": "fcb7c286-7dd4-4145-8e08-a8c50762617f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b24a5c5f-aac1-43ba-8fff-810d5b908a02.pdf",
            "news_date": "2023-11-07 16:40:18",
            "seo": "poly-medicure-ltd",
            "ltp": 1387.6,
            "ch": -98.10000000000014,
            "pch": -6.6029481052702526,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 25718,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "POLYMED",
            "disp": "Poly Medicure",
            "bse_code": 531768,
            "isin": "INE205C01021",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Declaration Of Unaudited Quarterly Financial Results For The Quarter Ended On 30Th September, 2023 On The Boatrd Meeting Held On 04Th November, 2023.",
            "news_body": "Pursuant to Regulations 30 and 33 of SEBI(LODR) Regulations, 2015, we are pleased to inform to the stock exchnage that the Board of directors at their meeting held today i.e. 04th November, 2023 approved the Unaudited Financial Results ( Consolidated & Standalone) fo rthe second quarter and half year ended on 30th September, 2023.",
            "news_id": "b71e5f3f-39d3-43eb-9b96-646b21b3b90c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=740d8085-bde9-4781-aaf0-b13e6e015cb2.pdf",
            "news_date": "2023-11-04 13:47:37",
            "seo": "poly-medicure-ltd",
            "ltp": 1387.6,
            "ch": -98.10000000000014,
            "pch": -6.6029481052702526,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 25718,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "POLYMED",
            "disp": "Poly Medicure",
            "bse_code": 531768,
            "isin": "INE205C01021",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Pursuant to Regulation 30(6) of SEBI (LODR) Regulations, 2015, we herby submit transcript of the Investor meet/call held on 8th August, 2023.",
            "news_id": "7d417ba7-efb9-4653-b4f8-7a5dd39ab8b6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=13cca35f-bd27-4478-a135-e45fe9036bd4.pdf",
            "news_date": "2023-08-16 19:34:10",
            "seo": "poly-medicure-ltd",
            "ltp": 1387.6,
            "ch": -98.10000000000014,
            "pch": -6.6029481052702526,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 25718,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "POLYMED",
            "disp": "Poly Medicure",
            "bse_code": 531768,
            "isin": "INE205C01021",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Pursuant to the provisions of Regulation 30 and 46(2)(oa) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, the audio recording of the Earnings Conference Call held on Tuesday, August 08, 2023, on the Unaudited Standalone and Consolidated financial results of the Company for the quarter ended June 30, 2023, is available on the Company's website at https://www.polymedicure.com/wp-content/uploads/2023/08/ICI3420230808148657.mp3.",
            "news_id": "f082c7e5-34fc-49d8-8885-65b93137706e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=984a9642-4168-4384-beae-1761f5b05ad6.pdf",
            "news_date": "2023-08-09 18:59:07",
            "seo": "poly-medicure-ltd",
            "ltp": 1387.6,
            "ch": -98.10000000000014,
            "pch": -6.6029481052702526,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 25718,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "POLYMED",
            "disp": "Poly Medicure",
            "bse_code": 531768,
            "isin": "INE205C01021",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Pursuant to the provisions of Regulation 30 and 46(2)(oa) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, the audio recording of the Earnings Conference Call held on Tuesday, August 08, 2023, on the Unaudited Standalone and Consolidated financial results of the Company for the quarter ended June 30, 2023, is available on the Company's website at https://www.polymedicure.com/wp-content/uploads/2023/08/ICI3420230808148657.mp3.",
            "news_id": "4f62f570-c8a9-4694-bd5f-acf990129b93",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=797bf7c3-aa19-4dec-81b8-c8efd23f4635.pdf",
            "news_date": "2023-08-09 18:57:25",
            "seo": "poly-medicure-ltd",
            "ltp": 1387.6,
            "ch": -98.10000000000014,
            "pch": -6.6029481052702526,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 25718,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "POLYMED",
            "disp": "Poly Medicure",
            "bse_code": 531768,
            "isin": "INE205C01021",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Quick Financial Results Subject To Outcome Of The Board Meeting Of The Company Held On Today I.E. 07Th August, 2023.",
            "news_body": "Pursuant to Regulation 30 and 33 of SEBI (LODR) Regulations, 2015, we are pleased to infor m the stock exchang that the Board of Directors at their meeting held today i.e. 07th August, 2023, at polycon house, A-27 & B-64, Industrial Esate, Bais Godam, Jaipur, Rajasthan- 302006, approved the following business.Unaudited Financial Results (Consolidated & Standalone) for the first quarter ended on 30th June, 2023.",
            "news_id": "67bce905-9f4e-4358-91d4-3bb77e2d2cca",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a9da687b-d471-4cdb-9be5-ca1b1f275ba4.pdf",
            "news_date": "2023-08-07 12:19:41",
            "seo": "poly-medicure-ltd",
            "ltp": 1387.6,
            "ch": -98.10000000000014,
            "pch": -6.6029481052702526,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 25718,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "POLYMED",
            "disp": "Poly Medicure",
            "bse_code": 531768,
            "isin": "INE205C01021",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for In Compliance Of Regulation 30 And 33 Of SEBI (LODR) Regulations, 2015, Outcome Of The Board Meeting Of The Company Held On Today I.E. 07Th August, 2023.",
            "news_body": "Dear Sir/Madam, <BR> Pursuant to Regulation 30 and 33 of SEBI (LODR) Regulations, 2015, we are pleased to inform the Stock Exchange that the Board of Directors at their meeting held today i.e. 07th August, 2023, at Polycon House A-27 & B-64, Industrial Estate, Bais Godam, Jaipur, Rajasthan - 302006, approved the following businesses:<BR> a) Unaudited Financial Results (Consolidate & Standalone) for the first quarter ended on 30th June 2023.<BR> b) Ratification of Remuneration to M/ s. Jai Prakash & Company, Cost Accountants appointed as Cost Auditors of the Company for the Financial Year 2023-24, subject to the approval of the shareholders in the forthcoming Annual General Meeting. <BR> c) Any other item.<BR> <BR> The meeting started at 10:30 am and concluded at 12:00 pm. <BR>",
            "news_id": "20db7db6-761a-4a8e-a3eb-8c8cf1718df9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2e856a02-fe24-4321-b9c7-0b4b5914ac8e.pdf",
            "news_date": "2023-08-07 12:10:15",
            "seo": "poly-medicure-ltd",
            "ltp": 1387.6,
            "ch": -98.10000000000014,
            "pch": -6.6029481052702526,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 25718,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "POLYMED",
            "disp": "Poly Medicure",
            "bse_code": 531768,
            "isin": "INE205C01021",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results - Outcome Of The Board Meeting Of The Company I.E. 9Th May, 2023",
            "news_body": "Dear Sir/Madam, Pursuant to Regulation 30 and 33 of SEBI (LODR) Regulations, 2015, We are pleased to inform the Stock Exchange that the Board of Directors at their meeting held today i.e.09th May, 2023, at 232-B, 3RD Floor, Okhla Industrial Estate, Phase-III,  New Delhi - 110020, approved the following businesses:a) Audited Financial Results (Consolidate & Standalone) for the year ended on 31st March 2023.b) Recommendation of Dividend of Rs. 3 (Three Rupees) per Equity Shares (60%) of Rs. 5 each for the Financial Year 2022-23, subject to the approval of shareholders.   The meeting commenced at 10.30 a.m. and concluded at 12.30 p.m.Kindly take a note of the same for your further needful and oblige us.",
            "news_id": "1ec41b14-8654-4761-808d-b5beef6ed2c9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=655b7b5d-a73c-4891-99f5-789b18c8e88a.pdf",
            "news_date": "2023-05-09 12:57:03",
            "seo": "poly-medicure-ltd",
            "ltp": 1387.6,
            "ch": -98.10000000000014,
            "pch": -6.6029481052702526,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 25718,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "POLYMED",
            "disp": "Poly Medicure",
            "bse_code": 531768,
            "isin": "INE205C01021",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting Of The Company Dated 09Th May, 2023",
            "news_body": "Dear Sir/Madam, <BR> Pursuant to Regulation 30 and 33 of SEBI (LODR) Regulations, 2015, We are pleased to inform the Stock Exchange that the Board of Directors at their meeting held today i.e.09th May, 2023, at 232-B, 3RD Floor, Okhla Industrial Estate, Phase-III,  New Delhi - 110020, approved the following businesses:<BR> a) Audited Financial Results (Consolidate & Standalone) for the year ended on 31st March 2023.<BR> b) Recommendation of Dividend of Rs. 3 (Three Rupees) per Equity Shares (60%) of Rs. 5 each for the Financial Year 2022-23, subject to the approval of shareholders.<BR>    <BR> The meeting commenced at 10.30 a.m. and concluded at 12.30 p.m.<BR> <BR> Kindly take a note of the same for your further needful and oblige us.",
            "news_id": "3a10c7f9-310f-4db1-b648-aee74d4e61a9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=89f053f2-5501-47ab-8f27-d43b1fd3855a.pdf",
            "news_date": "2023-05-09 12:53:59",
            "seo": "poly-medicure-ltd",
            "ltp": 1387.6,
            "ch": -98.10000000000014,
            "pch": -6.6029481052702526,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 25718,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "POLYMED",
            "disp": "Poly Medicure",
            "bse_code": 531768,
            "isin": "INE205C01021",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Quick Financial Results For The Quarter Ended 31St December, 2022",
            "news_body": "Pursuant to Regulation 30 and 33 of SEBI (LODR) Regulations, 2015, We are pleased to inform the Stock Exchange that the Board of Directors at their meeting held today i.e. 28th January, 2023, at 232-B, 3RD Floor, Okhla Industrial Estate, Phase-III,  New Delhi - 110020, approved the following businessesa) Unaudited Financial Results (Consolidate & Standalone) for the Third quarter and nine months  ended on 31st  December 2022. b) Constituted a Banking Operations Committee of the Company for the purpose of smooth functioning of the business operations of the Company.c) Any Other Item.Please note that the Board Meeting was started at 10.30 AM and concluded at 12:15 PM.",
            "news_id": "66c00b5e-51b0-4b5f-af81-2ab4ec63905c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=89955e22-4cfe-4bba-9cba-81d505e829d7.pdf",
            "news_date": "2023-01-28 12:46:52",
            "seo": "poly-medicure-ltd",
            "ltp": 1387.6,
            "ch": -98.10000000000014,
            "pch": -6.6029481052702526,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 25718,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "POLYMED",
            "disp": "Poly Medicure",
            "bse_code": 531768,
            "isin": "INE205C01021",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting Of The Company",
            "news_body": "Dear Sir/Madam, <BR> Pursuant to Regulation 30 and 33 of SEBI (LODR) Regulations, 2015, We are pleased to inform the Stock Exchange that the Board of Directors at their meeting held today i.e. 28th January, 2023, at 232-B, 3RD Floor, Okhla Industrial Estate, Phase-III,  New Delhi - 110020, approved the following businesses<BR> a) Unaudited Financial Results (Consolidate & Standalone) for the Third quarter and nine months  ended on 31st  December 2022. <BR> b) Constituted a Banking Operations Committee of the Company for the purpose of smooth functioning of the business operations of the Company.<BR> c) Any Other Item.<BR> <BR> Please note that the Board Meeting was started at 10.30 AM and concluded at 12:15 PM.",
            "news_id": "dcf12a6b-3e26-49f9-9533-315d8ee99d76",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=66eb7b04-de49-4cf0-9ef7-d7e52458ffbe.pdf",
            "news_date": "2023-01-28 12:39:25",
            "seo": "poly-medicure-ltd",
            "ltp": 1387.6,
            "ch": -98.10000000000014,
            "pch": -6.6029481052702526,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 25718,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "POLYMED",
            "disp": "Poly Medicure",
            "bse_code": 531768,
            "isin": "INE205C01021",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Regulation 23(9) Related Party Transaction FOR THE HALF YEAR ENDED 30 SEPTEMBER 2022.",
            "news_body": "Pursuant to Regulation 23(9) of Securities and Exchange Board of India (Listing Obligations & Disclosure Requirements) Regulations, 2015, please find enclosed herewith disclosures of Related Party Transactions for the half year ended September 30, 2022.",
            "news_id": "5f8c55ae-2b0b-406e-aa02-8f4be5c7a4b2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c11cc008-3589-437c-9c6a-04536f8126c0.pdf",
            "news_date": "2022-11-16 16:29:56",
            "seo": "poly-medicure-ltd",
            "ltp": 1387.6,
            "ch": -98.10000000000014,
            "pch": -6.6029481052702526,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 25718,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "POLYMED",
            "disp": "Poly Medicure",
            "bse_code": 531768,
            "isin": "INE205C01021",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting 04.11.2022",
            "news_body": "Pursuant to Regulation 30 and 33 of SEBI (LODR) Regulations, 2015, We are pleased to inform the Stock Exchange that the Board of Directors at their meeting held today i.e. 04th November, 2022, at 232-B, 3RD Floor, Okhla Industrial Estate, Phase-III,  New Delhi - 110020, approved the following businesses:<BR> a) Unaudited Financial Results (Consolidate & Standalone) for the Second quarter and half year ended on 30th September 2022.<BR> b) Any Other Item.<BR> <BR> The Meeting was started at 10.30 am and concluded on 12:15 pm.  <BR> <BR>",
            "news_id": "b8f6c5f7-3ff8-4489-9533-dc844b73752a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=94d0454b-72ec-410d-a847-2338fca504db.pdf",
            "news_date": "2022-11-05 16:15:31",
            "seo": "poly-medicure-ltd",
            "ltp": 1387.6,
            "ch": -98.10000000000014,
            "pch": -6.6029481052702526,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 25718,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "POLYMED",
            "disp": "Poly Medicure",
            "bse_code": 531768,
            "isin": "INE205C01021",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Standalone & Consolidated Financial Results For The Quarter Ended 0N 30.09.2022 Adopted In Board Meeting Held On 04.11.2022",
            "news_body": "Pursuant to Regulation 30 and 33 of SEBI (LODR) Regulations, 2015, We are pleased to inform the Stock Exchange that the Board of Directors at their meeting held today i.e. 04th November, 2022, at 232-B, 3RD Floor, Okhla Industrial Estate, Phase-III,  New Delhi - 110020, approved the following businesses:a) Unaudited Financial Results (Consolidate & Standalone) for the Second quarter and half year ended on 30th September 2022.",
            "news_id": "fd9bbf10-f674-454b-9d1a-afc44f6f0c8e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=62441c1e-17e5-4357-ac4d-12c85fb8f895.pdf",
            "news_date": "2022-11-04 12:38:58",
            "seo": "poly-medicure-ltd",
            "ltp": 1387.6,
            "ch": -98.10000000000014,
            "pch": -6.6029481052702526,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 25718,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "POLYMED",
            "disp": "Poly Medicure",
            "bse_code": 531768,
            "isin": "INE205C01021",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting Of The Company Held On 04.11.2022 To Consider Financial Statements For The Period Ended September 2022 And Other Business Matters",
            "news_body": "Pursuant to Regulation 30 and 33 of SEBI (LODR) Regulations, 2015, We are pleased to inform the Stock Exchange that the Board of Directors at their meeting held today i.e. 04th November, 2022, at 232-B, 3RD Floor, Okhla Industrial Estate, Phase-III,  New Delhi - 110020, approved the following businesses:<BR> a) Unaudited Financial Results (Consolidate & Standalone) for the Second quarter and half year ended on 30th September 2022.<BR> b) Any Other Item.<BR>  <BR>",
            "news_id": "f9119097-838d-44a5-bd24-1518855ec6f9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2d1e0859-7b23-4e96-9df2-34925eaac0cf.pdf",
            "news_date": "2022-11-04 12:34:09",
            "seo": "poly-medicure-ltd",
            "ltp": 1387.6,
            "ch": -98.10000000000014,
            "pch": -6.6029481052702526,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 25718,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "POLYMED",
            "disp": "Poly Medicure",
            "bse_code": 531768,
            "isin": "INE205C01021",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results(Standalone & Consolidated) For The Quarter Ended 30Th June 2022 In Compliance Of Regulation 30 And 33 Of SEBI (LODR) Regulations, 2015",
            "news_body": "Dear Sir/Madam, <BR> Pursuant to Regulation 30 and 33 of SEBI (LODR) Regulations, 2015, We are pleased to inform the Stock Exchange that the Board of Directors at their meeting held today i.e. 04th August, 2022, at 232-B, 3RD Floor, Okhla Industrial Estate, Phase-III,  New Delhi - 110020, approved the following businesses:<BR> a) Unaudited Financial Results (Consolidate & Standalone) for the first quarter ended on 30th June 2022.<BR>",
            "news_id": "f57bc0d8-f4f7-4717-9c90-d89af21e3ebe",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0493542f-b43a-4ba9-9983-b0d718fbd9b6.pdf",
            "news_date": "2022-08-04 12:28:34",
            "seo": "poly-medicure-ltd",
            "ltp": 1387.6,
            "ch": -98.10000000000014,
            "pch": -6.6029481052702526,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 25718,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "POLYMED",
            "disp": "Poly Medicure",
            "bse_code": 531768,
            "isin": "INE205C01021",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting Of The Company In Compliance Of Regulation 30 And 33 Of SEBI (LODR) Regulations, 2015 <BR>",
            "news_body": "Dear Sir/Madam, <BR> Pursuant to Regulation 30 and 33 of SEBI (LODR) Regulations, 2015, We are pleased to inform the Stock Exchange that the Board of Directors at their meeting held today i.e. 04th August, 2022, at 232-B, 3RD Floor, Okhla Industrial Estate, Phase-III,  New Delhi - 110020, approved the following businesses:<BR> a) Unaudited Financial Results (Consolidate & Standalone) for the first quarter ended on 30th June 2022.<BR> <BR> b) Allotted 18,050 Equity Shares of Rs. 5 each, pursuant to exercise of an option under Employee Stock Option Scheme, 2016.<BR> <BR> c) Ratification of Remuneration to M/ s. Jai Prakash & Company, Cost Accountants appointed as Cost Auditors of the Company for the Financial Year 2022-23, subject to the approval of the shareholders in the forthcoming Annual General Meeting.<BR> <BR> d) Resolution for Shareholders approval for re-appointment and remuneration of Mr. Vishal Baid as Sr. President (Sales and Marketing), of the Company, in the forthcoming Annual General Meeting.<BR>",
            "news_id": "9ff5488d-b1f5-45c1-97be-e9e2c6c0e9bb",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d6718efc-f735-4978-8ee6-526ddc7624c4.pdf",
            "news_date": "2022-08-04 12:21:17",
            "seo": "poly-medicure-ltd",
            "ltp": 1387.6,
            "ch": -98.10000000000014,
            "pch": -6.6029481052702526,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 25718,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "POLYMED",
            "disp": "Poly Medicure",
            "bse_code": 531768,
            "isin": "INE205C01021",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions For The Half Year Ended March 31, 2022",
            "news_body": "Dear Sir / Madam,  Pursuant to Regulation 23(9) of Securities and Exchange Board of India (Listing Obligations & Disclosure Requirements) Regulations, 2015, please find enclosed herewith disclosures of Related Party Transactions for the half year ended March 31, 2022. This is for your information and record. Thanking you.",
            "news_id": "015d34ca-4c20-481a-a937-932119ca0892",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6d8c6522-c85a-43be-96b2-7029db9a667a.pdf",
            "news_date": "2022-06-09 18:37:26",
            "seo": "poly-medicure-ltd",
            "ltp": 1387.6,
            "ch": -98.10000000000014,
            "pch": -6.6029481052702526,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 25718,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "POLYMED",
            "disp": "Poly Medicure",
            "bse_code": 531768,
            "isin": "INE205C01021",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Dear Sir/Madam, Please find enclosed the Investor Presentation covering the performance highlights of the Company for FY 2021-22.We have also uploaded the presentation on the Website of the Company at www.polymedicure.com      We request you to take the above on record and the same be treated as the necessary compliance under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.Thanking You,Yours Sincerely",
            "news_id": "8866f384-bd56-4e6d-aaf1-5eef8f8efb71",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ff178731-2714-4958-9d38-cb115b594d8b.pdf",
            "news_date": "2022-05-24 20:03:52",
            "seo": "poly-medicure-ltd",
            "ltp": 1387.6,
            "ch": -98.10000000000014,
            "pch": -6.6029481052702526,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 25718,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "POLYMED",
            "disp": "Poly Medicure",
            "bse_code": 531768,
            "isin": "INE205C01021",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Year Ended 31St March, 2022.",
            "news_body": "Dear Sir/Madam, <BR> Pursuant to Regulation 30 and 33 of SEBI (LODR) Regulations, 2015, We are pleased to inform the Stock Exchange that the Board of Directors at their meeting held today i.e. 24th May, 2022, at 232-B, 3RD Floor, Okhla Industrial Estate, Phase-III,  New Delhi - 110020, approved the following businesses:<BR> a) Audited Financial Results (Consolidate & Standalone) for the year ended on 31st March 2022.<BR> b) Recommendation of Dividend of Rs. 2.5 (Two and half Rupees) per Equity Shares (50%) of Rs. 5 each for the Financial Year 2021-22, subject to the approval of shareholders.<BR>",
            "news_id": "4e4a646f-1fd8-4717-921f-c05bb9148ada",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=382deb12-fafd-4f69-b16f-416223ef746e.pdf",
            "news_date": "2022-05-24 14:13:05",
            "seo": "poly-medicure-ltd",
            "ltp": 1387.6,
            "ch": -98.10000000000014,
            "pch": -6.6029481052702526,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 25718,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "POLYMED",
            "disp": "Poly Medicure",
            "bse_code": 531768,
            "isin": "INE205C01021",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting Of The Company Dated 24 May, 2022.",
            "news_body": "Dear Sir/Madam, <BR> Pursuant to Regulation 30 and 33 of SEBI (LODR) Regulations, 2015, We are pleased to inform the Stock Exchange that the Board of Directors at their meeting held today i.e. 24th May, 2022, at 232-B, 3RD Floor, Okhla Industrial Estate, Phase-III,  New Delhi - 110020, approved the following businesses:<BR> a) Audited Financial Results (Consolidate & Standalone) for the year ended on 31st March 2022.<BR> b) Recommendation of Dividend of Rs. 2.5 (Two and half Rupees) per Equity Shares (50%) of Rs. 5 each for the Financial Year 2021-22, subject to the approval of shareholders.<BR>",
            "news_id": "3e19440e-e489-4439-8dd5-f4207725345d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d75a7488-6721-48b9-95cf-2287dd57da83.pdf",
            "news_date": "2022-05-24 14:01:44",
            "seo": "poly-medicure-ltd",
            "ltp": 1387.6,
            "ch": -98.10000000000014,
            "pch": -6.6029481052702526,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 25718,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "POLYMED",
            "disp": "Poly Medicure",
            "bse_code": 531768,
            "isin": "INE205C01021",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Board Meeting Of The Company I.E. 31St January, 2022",
            "news_body": "Dear Sir/Madam, <BR> Pursuant to Regulation 30 and 33 of SEBI (LODR) Regulations, 2015, We are pleased to inform the Stock Exchange that the Board of Directors at their meeting held today i.e. 31st January, 2022, at 232-B, 3RD Floor, Okhla Industrial Estate, Phase-III,  New Delhi - 110020, approved the following businesses:<BR> a) Unaudited Financial Results (Consolidate & Standalone) alongwith Limited Review Report for the third quarter and nine months ended on 31st December 2021; and<BR> <BR> b) Any Other businesses.<BR> <BR> Kindly take a note of the same for your further needful and oblige us.<BR> Thanking You,<BR>",
            "news_id": "d7f01392-268a-41b1-8b48-329f33dbbef6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7183c9c1-2cfc-4abc-bf8f-91ed4c7eba6c.pdf",
            "news_date": "2022-01-31 12:38:08",
            "seo": "poly-medicure-ltd",
            "ltp": 1387.6,
            "ch": -98.10000000000014,
            "pch": -6.6029481052702526,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 25718,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "POLYMED",
            "disp": "Poly Medicure",
            "bse_code": 531768,
            "isin": "INE205C01021",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting Of The Company I.E. 31St January, 2022.",
            "news_body": "Dear Sir/Madam, <BR> Pursuant to Regulation 30 and 33 of SEBI (LODR) Regulations, 2015, We are pleased to inform the Stock Exchange that the Board of Directors at their meeting held today i.e. 31st January, 2022, at 232-B, 3RD Floor, Okhla Industrial Estate, Phase-III,  New Delhi - 110020, approved the following businesses:<BR> a) Unaudited Financial Results (Consolidate & Standalone) alongwith Limited Review Report for the third quarter and nine months ended on 31st December 2021; and<BR> <BR> b) Any Other businesses.<BR> <BR> Kindly take a note of the same for your further needful and oblige us.<BR> Thanking You,<BR>",
            "news_id": "1a05ccc1-c539-489d-b4fb-cfc7a1fd26f4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=601cf5b7-ac70-4bf1-88fc-cb20e24fe9f3.pdf",
            "news_date": "2022-01-31 12:31:43",
            "seo": "poly-medicure-ltd",
            "ltp": 1387.6,
            "ch": -98.10000000000014,
            "pch": -6.6029481052702526,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 25718,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "POLYMED",
            "disp": "Poly Medicure",
            "bse_code": 531768,
            "isin": "INE205C01021",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "OUTCOME OF BOARD MEETING - UNAUDITED HALF YEARLY FINANCIAL RESULTS.",
            "news_body": "Dear Sir/Madam, <BR> Pursuant to Regulation 30 and 33 of SEBI (LODR) Regulations, 2015, We are pleased to inform the Stock Exchange that the Board of Directors at their meeting held today i.e. 1st November, 2021, at 232-B, 3RD Floor, Okhla Industrial Estate, Phase-III,  New Delhi - 110020, approved the following businesses:<BR> a) Unaudited Financial Results (Standalone & Consolidated) for the Second quarter and half year ended on 30th September 2021.<BR> b) Allotted 19,775 Equity Shares of Rs. 5 each, pursuant to exercise of an option under Employee Stock Option Scheme, 2016. <BR> c) Other Routine Businesses.<BR> <BR> Kindly take a note of the same for your further needful and oblige us.<BR> Thanking You,<BR>",
            "news_id": "6f7e93cb-e02d-416f-8e9f-8c89c33033f6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=14ffdbd0-dba0-410d-869f-eb148d29f929.pdf",
            "news_date": "2021-11-01 12:58:43",
            "seo": "poly-medicure-ltd",
            "ltp": 1387.6,
            "ch": -98.10000000000014,
            "pch": -6.6029481052702526,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 25718,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "POLYMED",
            "disp": "Poly Medicure",
            "bse_code": 531768,
            "isin": "INE205C01021",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for OUTCOME OF BOARD MEETING DATED 01.11.2021",
            "news_body": "Dear Sir/Madam, <BR> Pursuant to Regulation 30 and 33 of SEBI (LODR) Regulations, 2015, We are pleased to inform the Stock Exchange that the Board of Directors at their meeting held today i.e. 1st November, 2021, at 232-B, 3RD Floor, Okhla Industrial Estate, Phase-III,  New Delhi - 110020, approved the following businesses:<BR> a) Unaudited Financial Results (Standalone & Consolidated) for the Second quarter and half year ended on 30th September 2021.<BR> b) Allotted 19,775 Equity Shares of Rs. 5 each, pursuant to exercise of an option under Employee Stock Option Scheme, 2016. <BR> c) Other Routine Businesses.<BR> <BR> Kindly take a note of the same for your further needful and oblige us.<BR> Thanking You,<BR>",
            "news_id": "1fd86aef-ceb8-4ec8-8f98-0d4dc694907b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=90b64ef3-eeb4-4988-a8de-b3a708a5a574.pdf",
            "news_date": "2021-11-01 12:53:45",
            "seo": "poly-medicure-ltd",
            "ltp": 1387.6,
            "ch": -98.10000000000014,
            "pch": -6.6029481052702526,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 25718,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "POLYMED",
            "disp": "Poly Medicure",
            "bse_code": 531768,
            "isin": "INE205C01021",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Quarterly Financial Results(Standalone & Consolidated) For The Quarter Ended 30.06.2021.",
            "news_body": "Dear Sir/Madam, <BR> <BR> Pursuant to Regulation 30 and 33 of SEBI (LODR) Regulations, 2015, We are pleased to inform the Stock Exchange that the Board of Directors at their meeting held today i.e. 29th July, 2021, at 232-B, 3RD Floor, Okhla Industrial Estate, Phase-III,  New Delhi - 110020, approved the enclosed businesses.<BR>",
            "news_id": "89e95d90-9592-43a6-9ed3-ea46207e4aa6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c678b8d5-153e-4a6f-a944-0bd3c9e45bf1.pdf",
            "news_date": "2021-07-29 13:40:20",
            "seo": "poly-medicure-ltd",
            "ltp": 1387.6,
            "ch": -98.10000000000014,
            "pch": -6.6029481052702526,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 25718,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "POLYMED",
            "disp": "Poly Medicure",
            "bse_code": 531768,
            "isin": "INE205C01021",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting Of The Company<BR> Ref: Compliance Of Regulation 30 And 33 Of SEBI (LODR) Regulations, 2015 <BR>",
            "news_body": "Dear Sir/Madam, <BR> <BR> Pursuant to Regulation 30 and 33 of SEBI (LODR) Regulations, 2015, We are pleased to inform the Stock Exchange that the Board of Directors at their meeting held today i.e. 29th July, 2021, at 232-B, 3RD Floor, Okhla Industrial Estate, Phase-III,  New Delhi - 110020, approved the enclosed businesses.<BR>",
            "news_id": "cef6e5a6-aeb4-428d-9067-584aa69f6efd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=85852b75-726c-41c1-846f-2edea4ea4957.pdf",
            "news_date": "2021-07-29 13:30:30",
            "seo": "poly-medicure-ltd",
            "ltp": 1387.6,
            "ch": -98.10000000000014,
            "pch": -6.6029481052702526,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 25718,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "POLYMED",
            "disp": "Poly Medicure",
            "bse_code": 531768,
            "isin": "INE205C01021",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Dear Sir/Madam, <BR> <BR> Please find enclosed the Investor Presentation covering the performance highlights of the Company for FY 2020-21.<BR> We have also uploaded the presentation on the Website of the Company at www.polymedicure.com<BR>       We request you to take the above on record and the same be treated as the necessary compliance under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.<BR>",
            "news_id": "0c4a819d-21c8-4071-a587-f24a8d7cbb74",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f5fb3655-9dd3-4b5c-979d-f259d5678450.pdf",
            "news_date": "2021-05-25 14:29:16",
            "seo": "poly-medicure-ltd",
            "ltp": 1387.6,
            "ch": -98.10000000000014,
            "pch": -6.6029481052702526,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 25718,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "POLYMED",
            "disp": "Poly Medicure",
            "bse_code": 531768,
            "isin": "INE205C01021",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Board Meeting Of The Company Dated 24Th May, 2021.",
            "news_body": "Dear Sir/Madam, <BR> Pursuant to Regulation 30 and 33 of SEBI (LODR) Regulations, 2015, We are pleased to inform the Stock Exchange that the Board of Directors at their meeting held today i.e. 24th May, 2021, at 232-B, 3RD Floor, Okhla Industrial Estate, Phase-III,  New Delhi - 110020, approved the following businesses:<BR> a) Audited Financial Results (Consolidate & Standalone) for the year ended on 31st March 2021.<BR> b) Recommendation of Dividend of Rs. 2.5 (Two and half Rupees) per Equity Shares (50%) of Rs. 5 each for the Financial Year 2020-21, subject to the approval of shareholders.<BR> <BR>",
            "news_id": "54108844-179a-4d05-b77d-1ccdc06e9560",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=954b21f9-bee0-4fc2-bc56-ec3f98052139.pdf",
            "news_date": "2021-05-24 14:18:08",
            "seo": "poly-medicure-ltd",
            "ltp": 1387.6,
            "ch": -98.10000000000014,
            "pch": -6.6029481052702526,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 25718,
            "exch": "NSE",
            "seg": "E"
        }
    ],
    "remarks": ""
}